Metabolic & Cardiometabolic
resistant starch decreases postprandial glucose
In plain terms: Does resistant starch lower blood sugar after a meal?
Part of: 🧪 resistant starch
Yes for the post-meal spike, but its longer-term fasting effect is small and needs fairly large daily doses.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Resistant starch (esp. high-amylose wheat RS2) lowers the acute postprandial glucose/insulin response; chronic fasting-glucose effect is small and dose-hungry (>28 g/d).
The evidence (24)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Pugh JE, Cai M, Altieri N, Frost G 2023 · Front Nutr | meta-analysis | supports | high | Meta-analysis in T2D/prediabetes: resistant starch types 1 and 2 lowered acute postprandial glucose (SMDs -0.38 and -0.29); RS2 improved acute response. |
| Sandberg JC, Björck IME, Nilsson AC 2017 · Nutrition Journal | RCT | supports | moderate | Whole-grain rye with RS2 supplementation improved glucose tolerance and gut-hormone responses over an extended postprandial window in healthy subjects. |
| Tian J, Wang N, Song C, Kong F, Wen C, Jiang Z, Song S 2026 · Foods (Basel, Switzerland) | animal | supports | low | In vivo rice-starch gel model; Ca2+-alginate crosslinking raised RS 7.7%->14.4%; postprandial iAUC fell 747.2->591.7 mmolmin/L (p<0.05) vs uncrosslinked RS gel. |
| Itkonen ST, Chapelais M, Calvez J, Airinei G, Benamouzig R, Pajari AM, Gaudichon C 2025 · Food Res Int | observational | mixed | moderate | Ileal starch digestibility study: faba-bean resistant starch only partly explained the lower postprandial glycemic response in healthy humans. |
| Xiong K, Wang J, Kang T, Xu F, Ma A 2021 · Br J Nutr | meta-analysis | supports | moderate | Fasting glucose -0.09 mmol/L (-0.16 at >28 g/d); HOMA-IR -0.33; fasting insulin NS |
| Gourineni V, Stewart ML, Wilcox ML, Maki KC 2020 · Foods | RCT | supports | moderate | Nutritional bar with potato-based resistant starch attenuated postprandial glucose and insulin responses vs control in healthy adults. |
| Lee CM, Jeong OY, Park HS, Seo J, Park S, Lee KM, Jin M, Choi IR, Han JH 2025 · Frontiers in plant science | animal | supports | low | 16 Korean rice accessions; high-RS/SDS lines (Seullomi1/2, Dodamssal) had lower in vitro GI (<60) and, in mice (n=5/group), significantly reduced blood glucose spikes at 30 min vs commercial rice. |
| Collins SM, Bernadette Egan M, Whyte MB, Denise Robertson M 2025 · Diabetic Medicine | RCT | supports | moderate | Partial substitution of dietary starch with resistant starch lowered postprandial glucose and glycemic variability (MAGE) in people with type 2 diabetes. |
| Duan Y, Hou L, Bi J, Xiao S, Zhang Y, Zhan W, Du J, Ding W, Wu Y, Wang X 2026 · International journal of biological macromolecules | animal | supports | low | Hyperglycemic Drosophila (T2DM model); WS-MA complex (RS5) 45% replacement vs sucrose/corn-flour control: blood glucose -46%, triglycerides -27%. |
| Corrado M, Savva GM, Ahn-Jarvis JH, Oyeyinka SA, Edwards CH, Hazard BA 2025 · Food & function | RCT | contradicts | high | Human RCT (n=26), CGM, crossover: high-amylose (sbeII mutant, RS-enriched) bread vs isoglucidic WT bread. Max 2h glucose rise: -0.08+/-0.12 mmol/L difference, p=0.514 (null), despite ~7% lower in vitro digestibility (p=0.006). |
| Dainty SA, Klingel SL, Pilkey SE, McDonald E, McKeown B, Emes MJ, Duncan AM 2016 · J Nutr | RCT | contradicts | moderate | Randomised double-blind crossover, n=24 adults at increased T2D risk (mean age 55, BMI 30): 25 g/d HAM-RS2 (high-amylose maize) bagel vs control wheat bagel for 56 d each. Outcome was a 75 g OGTT on days 1 and 57, not the acute response to an RS food: 'Fasting and postprandial OGTT glucose concentrations did not differ between the RS and control bagel treatments on study days 1 or 57.' Insulin iAUC 2-h -23.3% (P<0.008), HOMA-IR -23.1% (P=0.04). Abstract-only. |
| Suárez-Diéguez T, Olvera Nájera M, Silva M, López-Rodríguez G, Ariza-Ortega JA, García-Tejedor A, Nieto JA 2025 · Nutrients | animal | supports | low | Diabetic Wistar rats; faba-bean retrograded RS (15/30% diet replacement) vs untreated diabetic controls: postprandial hyperglycemia attenuated ~29% (24.56/25.02 vs 34.65 mmol/L); fasting glucose -22%. |
| Wei J, Fan Z, Deng Y, Pan K, Shi R, Hu J, Liu B 2026 · Nutrients | RCT | supports | moderate | Minimally cooked (high-RS) potato improved glycemic response across two meals and insulin sensitivity of rice-potato mixed meals in an acute RCT. |
| Abdi SAH, Abdi SIA, Ali MH, Balani NA, Balani NA, Jacob HL, Seyfi A, Al Shabout GH, Hamza DN, Al-Talabani AD, Khan R 2025 · Cureus | observational | supports | low | Systematic review of RCTs: dietary fiber interventions including resistant starch improved glycemic control in diabetes. ⚠️ RETRACTED — not counted |
| Zeng J, Li P, Chen H, Li F, He X, Liu G, Zhou P, Zhao Z, Zhang Y, Zhang M, Deng Y 2026 · NPJ science of food | animal | supports | low | High-fat-diet diabetic mice, 6-wk feeding; two resistant-starch-rich rice varieties (RSRR) vs common rice: reduced fasting glucose, blood lipids, and postprandial glucose response (KTD variety most effective). |
| Tavares IRG, do Carmo EÉA, da Silveira Alvares T 2026 · Curr Nutr Rep | observational | supports | low | Integrative review: resistant starch consistently associated with improved postprandial glucose and cardiometabolic risk markers in human trials. |
| Peng X, Fan Z, Wei J, Liu R, Lou X, Hu J, Xing Y 2024 · Nutrients | RCT | mixed | moderate | Cold-stored (retrograded, higher-RS) millet did NOT outperform fresh-cooked for second-meal glycemia; RS content alone did not predict the effect. |
| Siminiuc R, Vîrlan A 2026 · Foods | RCT | supports | moderate | Human crossover, n=10 healthy adults (20-35 y, normal BMI), ISO 26642 GI: 83.03 +/- 15.02 freshly cooked vs 43.55 +/- 6.99 after 2160 h at -18 C; repeated-measures ANOVA p<0.0001, every condition except 6 h at 20 C significant vs fresh; the 4 C arm reached 53.86 at 120 h. RS 1.78% -> 3.98% is a SEPARATE in-vitro assay (n=3 per condition), and r=-0.935 (R2=0.8735) is a Pearson correlation across the NINE condition means, not across participants. Storage regime, not resistant starch, was the assigned exposure. |
| Di Rosa C, De Arcangelis E, Vitelli V, Crucillà S, Angelicola M, Trivisonno MC, Sestili F, Blasi E, Cicatiello C, Lafiandra D, Masci S, Messia MC, De Gara L, Marconi E, Khazrai YM 2023 · Nutrients | RCT | supports | low | HA bread/biscuits (~12% starch as RS) significantly lower GI; n=10 |
| Xu F, Wang Y, Li H, Xu G, Jiang W, Li M, Dai L, Wang X, Xu B 2026 · International journal of biological macromolecules | animal | supports | low | C57 mice; PS-HTPs complex (peptide-modified potato starch, RS +23.28%, SDS +5.25%) vs native potato starch: peak blood glucose -42.0%. Acute single-meal, food-engineering model. |
| Belobrajdic DP, Regina A, Klingner B, Zajac I, Chapron S, Berbezy P, Bird AR 2019 · Nutrients | RCT | supports | moderate | High-amylose wheat bread lowered postprandial glycemic response vs conventional |
| Steele TJ, Maningat CC, Seib PA, Haub MD, Rosenkranz SK 2021 · Curr Dev Nutr | RCT | tested-null | moderate | Resistant wheat starch type 4 vs native wheat starch: glucose attenuation depended on testing protocol/food matrix, not uniform across conditions. |
| Maiya M, Adorno A, Toulabi SB, Tucker WJ, Patterson MA 2023 · Nutrition Research | observational | supports | low | Narrative review of randomized trials: resistant starch improved cardiometabolic outcomes including postprandial glucose/insulin handling. |
| Liu J, Meng Y, Ma A, Chang R 2025 · NPJ science of food | animal | supports | low | Mice; bionic grain-resistant corn starch (RS 9.3%->22.6% via gellan-gum/soy-protein encapsulation) vs native corn starch: peak postprandial glucose 11.98->9.58 mmol/L. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.